Overall, we show in this study using multiple approaches, including specific genetic deletion of Jak2 in myeloid cells that leads to accelerated atherosclerosis that is recapitulated by systemic JAK2 inhibition in vivo. Here, JAK2 is linked to atherosclerosis.